Trump Unveils Up to 200% Tariffs on Imported Generic Drugs, Escalating Global Trade Tensions
The U.S. president plans sweeping tariffs on imported generic medicines in a bid to bring pharmaceutical manufacturing back to America, a move that could reshape global supply chains, increase production costs and trigger fresh uncertainty across the healthcare industry.